<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr71-1759720X20912646">
 <label>71</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huang</surname>
    <given-names>Y-H</given-names>
   </name>
   <name>
    <surname>Hsiao</surname>
    <given-names>L-T</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>Y-C</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>
  <article-title>Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B</article-title>. 
  <source>J Clin Oncol</source>
  <year>2013</year>; 
  <volume>31</volume>: 
  <fpage>2765</fpage>â€“
  <lpage>2772</lpage>.
  <pub-id pub-id-type="pmid">23775967</pub-id>
 </mixed-citation>
</ref>
